CG
ANAB icon

Cutler Group’s AnaptysBio ANAB Stock Holding History

Cutler Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,000
Closed -$2K – 3745
2023
Q2 		$2K Buy
+3,000
New +$60.8K ﹤0.01% 2954
2021
Q2 		– Sell
-1,000
Closed -$1K – 5622
2021
Q1 		$1K Buy
+1,000
New +$25.2K ﹤0.01% 5115
2020
Q2 		– Sell
-5,200
Closed -$17K – 4325
2020
Q1 		$17K Sell
5,200
-23,400
-82% -$355K ﹤0.01% 2387
2019
Q4 		$27K Buy
28,600
+27,100
+1,807% +$641K ﹤0.01% 2020
2019
Q3 		$3K Buy
+1,500
New +$71.4K ﹤0.01% 3262
2019
Q1 		– Sell
-2,000
Closed -$5K – 3978
2018
Q4 		$5K Sell
2,000
-34,600
-95% -$2.57M ﹤0.01% 2893
2018
Q3 		$134K Buy
+36,600
New +$3.04M 0.01% 1043
2018
Q2 		– Sell
-6,500
Closed -$7K – 4143
2018
Q1 		$7K Buy
6,500
+4,500
+225% +$507K ﹤0.01% 3020
2017
Q4 		$25K Buy
+2,000
New +$147K ﹤0.01% 2363

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Cutler Group's ANAB Position: Q3 2023 in Review

Cutler Group sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 1,500 shares — an estimated $30K sold.

Cutler Group first reported a position in ANAB in Q4 2017 and held it in 16 quarters. The position peaked at $759K in Q4 2018. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.

  • Cutler Group reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,500 AnaptysBio shares in Q3 2023, an estimated $30K.
  • Cutler Group first reported a position in AnaptysBio in Q4 2017 and held it in 16 quarters.
  • Cutler Group's AnaptysBio position peaked at $759K in Q4 2018.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.